Complement activation in children with Streptococcus pneumoniae associated hemolytic uremic syndrome
Open Access
- 4 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 36 (5), 1311-1315
- https://doi.org/10.1007/s00467-021-04952-w
Abstract
Background: Hemolytic uremic syndrome caused by invasive pneumococcal disease (P-HUS) is rare in children and adolescents, but accompanied by high mortality in the acute phase and complicated by long-term renal sequelae. Abnormalities in the alternative complement pathway may additionally be contributing to the course of the disease but also to putative treatment options. Methods: Retrospective study to assess clinical course and laboratory data of the acute phase and outcome of children with P-HUS. Results: We report on seven children (median age 12 months, range 3–28 months) diagnosed with P-HUS. Primary organ manifestation was meningitis in four and pneumonia in three patients. All patients required dialysis which could be discontinued in five of them after a median of 25 days. In two patients, broad functional and genetic complement analysis was performed and revealed alternative pathway activation and risk haplotypes in both. Three patients were treated with the complement C5 inhibitor eculizumab. During a median follow-up time of 11.3 years, one patient died due to infectious complications after transplantation. Two patients showed no signs of renal sequelae. Conclusions: Although pathophysiology in P-HUS remains as yet incompletely understood, disordered complement regulation seems to provide a clue to additional insights for pathology, diagnosis, and even targeted treatment.Keywords
Funding Information
- Projekt DEAL
This publication has 18 references indexed in Scilit:
- New insights into the pathogenesis ofStreptococcus pneumoniae-associated hemolytic uremic syndromePediatric Nephrology, 2020
- Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in GermanyPLOS ONE, 2019
- Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in ChildhoodFrontiers in Pediatrics, 2018
- Pneumococcal haemolytic uraemic syndrome in the postvaccine eraArchives of Disease in Childhood, 2018
- 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescentsJournal of Hypertension, 2016
- An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenPediatric Nephrology, 2015
- Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndromeJournal of Medical Microbiology, 2013
- Epidemiology of Streptococcus pneumoniae-Induced Hemolytic Uremic Syndrome in Utah ChildrenThe Pediatric Infectious Disease Journal, 2010
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Hemolytic Uremic Syndrome Associated with Invasive Pneumococcal Disease: The United Kingdom ExperienceThe Journal of Pediatrics, 2007